Abstract-Elevated cholesterol levels are associated with a greater risk of developing cardiovascular disease and other illnesses, making it a prime candidate for detection on a disposable biosensor for rapid point of care diagnostics. One of the methods to quantify cholesterol levels in human blood serum uses an optically mediated enzyme assay and a bench top spectrophotometer. The bulkiness and power hungry nature of the equipment limits its usage to laboratories. Here, we present a new disposable sensing platform that is based on a complementary metal oxide semiconductor process for total cholesterol quantification in pure blood serum. The platform that we implemented comprises readily mass-manufacturable components that exploit the colorimetric changes of cholesterol oxidase and cholesterol esterase reactions. We have shown that our quantification results are comparable to that obtained by a bench top spectrophotometer. Using the implemented device, we have measured cholesterol concentration in human blood serum as low as 29 µM with a limit of detection at 13 µM, which is approximately 400 times lower than average physiological range, implying that our device also has the potential to be used for applications that require greater sensitivity.
become widespread in their use for managing diabetes [6] . Furthermore, metabolite biomarkers of different diseases are also becoming increasingly well understood [7] , [8] which paves the way for developing new diagnostic system. Here we report on the development of an electronic device that is capable of detecting cholesterol whose variable concentrations are predictive of cardiovascular diseases development [9] . We anticipate that future development will contribute to the introduction of stratified and precision medicine.
Elevated cholesterol levels are well known for their association with an increased risk of coronary heart disease (angina or heart attack), narrowing of the arteries (atherosclerosis), stroke, peripheral heart disease, and hypertension [10] , [11] . Such conditions often correlated with poor diet, an excessive fat intake, lack of exercise and other lifestyle choices [12] . This pose a global threat to public health and consume considerable healthcare resources [13] . Hence, cholesterol diagnosis has already entered systematic use in many healthcare systems with prescription of cholesterol lowering drugs e.g. statins.
It is estimated that approximately 73.5 million adults have high amounts of LDL * cholesterol in the US alone [14] and approximately 17 million deaths a year, nearly one third of the total [15] , arise through cardiovascular disease.
One of the diagnostic methods for quantifying cholesterol concentration depends on enzyme-based assays that require a classical spectrophotometer to measure changes in colour products from those enzyme reactions [16] . A general purpose spectrophotometer would incorporate a sophisticated setup of a white light source, a monochromator containing a diffraction grating and a light transducer that converts light into electrical signal such as a charge-coupled device (CCD), a photodiode or a photomultiplier tube [17] . The wide spectrum range of the spectrophotometer makes it bulky and power hungry which consequently confines its usefulness to laboratories and hospitals.
The working principle of a spectrophotometer to measure colour changes of enzyme assay depends on setting up the monochromator's output light to a specific wavelength that matches the assay's absorption peak wavelength. By using the same principle, in this work we propose a disposable sensing platform that is designed to operate using a single wavelength. By careful selection of the right combination of enzyme absorption wavelength, light source wavelength and detector spectrum, a simpler-disposable version of the spectrophotometer can be implemented using components that can be industrially mass-produced.
This work is licensed under a Creative Commons Attribution 3.0 License. For more information, see http://creativecommons.org/licenses/by/3.0/ The platform that we have implemented comprises a complementary metal oxide semiconductor (CMOS)-based photodiode array and an off-the-shelf light emitting diode (LED). The photodiode array is fabricated using commercial standard CMOS process, which is readily available for low-cost mass-production [18] .
Photodiodes made in a CMOS process are generally sensitive to light in the 200 nm to 1100 nm range, owing to the bandgap of silicon (1.12 eV). This range makes them suitable for colorimetric enzyme assays that use visible light or fluorescent mediators, which often use wavelengths in the range 400 nm to 700 nm. A colour change in this range of enzyme assays, e.g. cholesterol ester hydrolase [19] , cholesterol dehydrogenase [20] , cholesterol esterase [21] and cholesterol oxidase [22] can be exploited to extract cholesterol levels. In this work, we have employed cholesterol oxidase and cholesterol esterase assay to quantify total cholesterol from human blood serum samples.
II. MATERIALS AND METHODS

A. Assay Materials
Cholesterol oxidase from Streptomyces (C8649, 23 Units/mg solid) was purchased from Sigma-Aldrich, as was cholesterol (C3045), o-Dianisidine dihydrochloride (F5803), triethanolamine hydrochloride (T9534), Triton™X-100 (T9284) and horseradish peroxidase (P8250, 163 Units/mg solid). Cholesterol esterase from Pseudomonas fluorescens (C9281-5 Units/mg solid) was purchased from SigmaAldrich as was taurocholic acid sodium salt hydrate (T4009) and sodium cholate hydrate (C1254). Sodium chloride was purchased from VWR (27810). Human serum from human male AB plasma, USA origin, sterile-filtered was sourced from Sigma Aldrich (H4522). The serum cholesterol concentration was stated as 110 -210 mg/dl.
B. Enzyme Assay Methods
Approximately 30% of cholesterol in serum is present in 'free' form (typically, 40 mg/dl -85 mg/dl) while the remainder is assimilated into cholesteryl esters with long-chain fatty acids [23] . In order to measure the total cholesterol in serum, a triple enzyme assay was used comprising two cholesterol reactions and an optical product step via the activity of peroxidase. First, the enzyme cholesterol esterase was used to hydrolyse cholesterol esters to free cholesterol [24] . The reaction is as below:
The second reaction involved the addition of cholesterol oxidase, which is an oxidoreductase that uses molecular oxygen as an electron acceptor to reduce oxygen to hydrogen peroxide [25] . In this reaction, free cholesterol in serum with the addition of free cholesterol from cholesterol esterase reaction is used by the cholesterol oxidase, as a mean of quantification. The cholesterol oxidase catalysed reaction is as below:
The third reaction involved the production of a coloured product to be measured optically. In the presence of H 2 O 2 produced from cholesterol oxidase, o-Dianisidine is oxidised to a coloured product with a progressively deep orange colour, amenable to detection by absorbance of green light. The intensity of the coloured product is dependent on the concentration of H 2 O 2 , which is proportional to cholesterol concentration.
Therefore, these three enzyme reactions allow for a colorimetric measurement of total cholesterol in serum.
C. CMOS Chip
An integrated circuits chip was designed using Cadence Design Software version 5.10, and fabricated in the AMS 0.35 µm CMOS process provided by Austriamicrosystems. The chip incorporates an array of 16 × 16 photodiodes with integrated addressing and readout circuits. Each chip measured 3.4 mm by 3.6 mm, with an active sensor array area of 1.6 mm by 1.6 mm. The photodiode pixel used for these experiments measured 10 µm × 24 µm.
In this chip we used a typical active pixel sensor (APS) design that incorporates a photodiode and three transistors to enable the readout of data [26] . The schematic of a single pixel is shown in Fig. 1a . As can be seen in the timing diagram of Fig. 1b , each measurement cycle begins at t = t 0 when V rst = V dd . From t 0 to t 1 the junction capacitance of the diode is precharged to be V dd . At t = t 1 the circuit enters the integration phase. Depending on the integration time, a different photocurrent I ph corresponds to a change of the voltage, V d , across the diode. At t = t 2 the diode voltage is sampled and read-out using the 'sel' signal on M3. As can be seen from Fig. 1b the sampled voltage decreases as the light intensity is increased (e.g. for traces labelled V d1 and V d2 ). However, if the detector is saturated, the diode will have completely discharged before t = t 2 . This is illustrated by the trace labelled V d3 . Fig. 1c shows the CMOS chip after packaging. The chip was packaged by attaching it to a chip carrier using EPO-TEK H74 epoxy (Epoxy Technology Inc.). The epoxy, heated to 150°C, formed a strong bond between the chip and the carrier. A wirebonding machine was then used to make the connections between the chip and chip carrier. Next, a 2 mm cube of polydimethylsiloxane (PDMS) was placed on the sensor active area as protection before adding EPO-TEK 302-3M (Epoxy Technology Inc.) to protect the bond-wires. This epoxy was cured at room temperature for duration of 24 hours. The PDMS was then removed from the sensor surface before cleaning the sensor with acetone and isopropanol. Finally, a section of polypropylene centrifuge tube (Fisherbrand) was attached with more EPO-TEK 302-3M and cured at 65°C for 3 hours to allow for aqueous measurements to occur on the chip surface.
D. Experimental Setup
In order to operate the photodiode array chip, a printed circuit board (PCB) platform was designed to integrate the chip with an ARM mbed STM32 Nucleo-F334R8 board (STMicroelectronics, UK) as shown in Fig. 2a . The mbed microcontroller was programmed to provide addressing signals Fig. 3 . The spectral response of the photodiode, the enzyme solution after a reaction has occurred, and the green LED emission characteristics. The peak in the LED emission intensity occurs very near the optimum in the overlap in the enzyme absorbance and PD sensitivity spectra.
and to acquire the output readings from the array. These readings were then transferred by a universal serial bus (USB) to a computer based LabVIEW program, in which the data was processed and analysed. Fig. 2b shows the concept of utilising the experimental setup in conjunction with a LED to quantify the coloured product from the enzyme assay.
III. EXPERIMENTAL RESULTS AND DISCUSSIONS
A. Optical Evaluation of the System
The optical characteristics of the photodiode and a completed cholesterol reaction mix, were evaluated to examine their spectral relationship. First, the spectrum of the photodiode was measured using a TMc300 monochromated light source (Benthem Instruments), swept between 350 nm and 1000 nm. The photodiode responsivity shown in Fig. 3 has a maximum peak at c. 600 nm. The enzyme spectrum was then measured using a TFProbe MSP300 spectrometer (Angstrom Sun Technologies) after all the substrate had been consumed. The measurement showed that the enzyme spectrum has an absorption peak at c. 460 nm. From both traces, it can be seen that there is an overlap between sensitivity of the photodiode and the absorbance spectrum of the enzyme assay, around 500 nm. Based on this data, a green LED was chosen to have a peak spectrum close to 500 nm. An off-the-shelf commercial green LED was measured using the same spectrometer and is shown to have a peak at 505 nm, which was well positioned at the overlap of the two traces.
B. Electrical Evaluation of the System
In this section, we present the electrical characteristics of the photodiode array, in terms of dynamic range and noise performance. The photodiode array has a minimum light detection of 280 nW/cm 2 and a total dynamic range of 56 dB. In terms of noise, the chip was designed to have an array of 256 sensors, which had proven to be able to outperform a single sensor. In our previous work, we had demonstrated that an array of ion sensitive field effect transistor (ISFET) sensors could be used as an average to reduce noise [27] . In the same way, the photodiode array was used to reduce the noise of the combined assay signal, since we can obtain data from a single photodiode, or we can average data from 2 to 2 8 photodiodes. Following Gaussian statistics, the noise is reduced as a function of √ N , where N is the number of sensors. Fig. 4 illustrates a typical time-course signal obtained from the chip for a very low concentration of cholesterol. As can be seen, the signal obtained from a single sensor has a very large noise, whereas the signal obtained from an average of all the sensors has a much reduced noise. Therefore, all the subsequent measurements were done using the average of all the photodiodes. Furthermore, chip-to-chip variation was also evaluated using seven different chips and found to have a standard deviation of 5.8 mV. This slight difference is due to CMOS process parameter variations, which we minimised by using control measurement as a reference for each set of measurements as demonstrated in Section D.
C. Spectrophotometric Measurement to Different Cholesterol Concentrations
In this section, we have quantified cholesterol in solution and serum using our proposed enzyme assay, which was measured with a bench top spectrophotometer. Initially, enzymatic activity of cholesterol oxidase was evaluated using a coupled colorimetric assay in which o-Dianisidine, in the presence of peroxidase and H 2 O 2 (a product of cholesterol oxidase), is oxidised. The absorbance of the oxidised o-Dianisidine was monitored at 505 nm (similar to the LED peak) and 25°C with a UV-2550 Shimadzu Spectrophotometer. 0.5% (w/v) cholesterol with 10% (w/v) Triton™X-100 was first made up as stock, which is equivalent to 13 mM. All experiments were performed using a cuvette with 1 ml of solution and the enzyme assay mix is shown in Table 1 . Absorbance measurements as a function of time for different cholesterol concentrations were then obtained using the spectrophotometer. The data in Fig. 5a show clearly that each absorbance levels have well differentiated magnitudes. As the substrate concentration is increased so is the final absorbance value. The velocity of the enzyme reaction was therefore measured by quantifying the amount of product formed per minute during the initial stage of the reaction, in order to extract Michaelis-Menten constant, which was 40 ± 7 µM. Using the velocity and cholesterol concentration, the reaction rate versus concentration plot is presented in Fig. 5b . From the data, Lineweaver-Burk double reciprocal plot (shown in the inset of Fig. 5b ) is also created using the inverse of the velocity versus inverse of the cholesterol concentration.
This was then moved on to measure the different dilutions of serum, which correspond to different cholesterol concentrations in solution. The serum was first pre-treated with cholesterol esterase for 10 minutes at 37°C to release free cholesterol from the esterified form prior to a reaction taking place. Serum was added to an assay mix containing 34 mM triethanolamine pH 7.5, 0.25% (w/v) taurocholic acid sodium salt hydrate, 0.25% (w/v) sodium cholate hydrate, 0.14% (w/v) sodium chloride and 0.14 Units cholesterol esterase. Following preincubation, 0.32 mM o-Dianisidine, 3 Units of peroxidase and 0.3 Units of cholesterol oxidase were added, and the absorbance of the oxidised o-dianisidine was monitored at 505 nm and 37°C with a UV-2550 Shimadzu Spectrophotometer. As expected, the results from different serum dilutions agree well with the results from cholesterol made in solution (data not shown).
D. Optimizing Enzyme Concentration
We first introduced a control experiment to define a reference baseline for our measurements. This was then followed by testing a number of cholesterol oxidase concentrations to identify which one would give an optimal measurable response within a short-time period, and which could be used for subsequent experiments. This was initially tested by spectrophotometry and later confirmed on the photodiode.
Triethanolamine buffer, o-Dianisidine, cholesterol (prepared as a solution in Triton™X-100) and peroxidase were added to the sensor at concentrations described above. The final cholesterol concentration used in this assay was 0.429 mM (17.5 mg/dl), as recommended by Sigma. The reaction was initiated immediately by the addition of cholesterol oxidase in equivalent reaction volumes. The optical path length from the sensor surface to the photodiode was therefore the same. The voltage change observed in Fig. 6 is a direct result of increasing absorbance over time. The sharp increase in measured voltage immediately after the peroxidase was a result of the solution being mixed, a transient effect. The photodiode chip is very robust and easily withstands repeated cleaning and reuse by rinsing with acetone, isopropanol and DI water and blow-drying with nitrogen gas. The data shown in this paper was taken from one chip for consistency.
As expected, the higher the concentration of cholesterol oxidase added the more rapid the response, with 0.66 Units of cholesterol oxidase reaching saturation level of approximately 0.63 V, as shown in Fig. 6 . At lower concentrations of cholesterol oxidase, the voltage increased more slowly, but did tend towards the same final absorbance (and voltage). The absence of cholesterol (control experiment) gave no response, confirming that the sensor was substrate specific. This experiment validated the sensor as a means of measuring cholesterol oxidase enzyme activity and allowed us to select a concentration of 0.33 Units of cholesterol oxidase for subsequent experiments, as this concentration gave a quick temporal response and reliable measurement.
E. Measurement of Photodiode Response to Different Cholesterol Concentrations in Serum
The photodiode's response to cholesterol present in serum was then measured, by first pretreating the serum with cholesterol esterase followed by the addition of cholesterol oxidase.
Serum was supplied at a stated cholesterol concentration of between 2.8 mM -5.4 mM (110 mg/dl -210 mg/d). Using absorption method, the exact value was determined to be 3.5 mM by the National Health Service's (NHS) laboratories of The Queen Elizabeth University Hospital, Glasgow. The stock serum was diluted in triethanolamine buffer to specific final concentrations so they were within the detectable range of the photodiode.
Our data shows that the CMOS photodiode/LED sensor system yields variable response to different cholesterol concentrations, as shown in Fig. 7a . Each of the cholesterol concentration measurements were repeated three times for consistency and repeatability using the same chip. The behaviour we observed was a good match with the spectrophotometer data (Fig. 5) indicating that the assay works well on the CMOS chip and that the miniature optical measurement system is comparable to conventional lab-based spectrophotometry. The voltage readout increased monotonically with cholesterol concentration. No change in voltage was observed when cholesterol was omitted. Each reaction reached a different final plateau voltage, signifying consumption of substrate and corresponding to the substrate concentration used.
Endpoint voltages as a function of final cholesterol concentration is plotted in Fig. 7b . As can be noticed, the lowest cholesterol concentration in pure human blood serum that we measured is at 29 µM. The limit of detection of the assay is also determined by taking three times of the standard deviation from control experiment, which is approximately 13 µM. The total cholesterol in human blood for a healthy individual should be 5 mM or lower [28] , hence our device has the potential to be also used for more sensitive assays.
Similar to data analysis used for the spectrophotometer, the initial velocity was plotted against cholesterol concentrations in serum to calculate the K M value. K M was found to be 80 ± 1 µM using the new method. The data was obtained using the velocity versus concentration plot and LineweaverBurk double reciprocal plot in Fig. 7c . The result is in good agreement with the value obtained from the spectrophotometer. The work has therefore demonstrated that a low-cost and simple green LED/photodiode system has the capability to replicate the quantification of cholesterol in serum as a bench top spectrophotometer.
IV. CONCLUSION Elevated cholesterol is associated with an increased risk of developing cardiovascular disease with resultant high levels of morbidity and mortality. Monitoring the cholesterol levels of a patient in a point-of-care setting would make significant progress towards controlling cardiovascular disease, and would help save the lives of those affected, with a concomitant reduction in healthcare costs. Currently spectrophotometry is the gold standard used to determine cholesterol levels. Here, a method to determine the relative amounts of cholesterol in serum has been demonstrated using a miniaturised derivation from the spectrophotometric assay, by using a CMOS system. The assay method has been shown to be sensitive enough to detect serum cholesterol levels in a concentration dependent manner spanning the range of 29 µM to 231 µM, and therefore has the potential to be further developed as a practical handheld sensor device. Future challenges will include creating an assay sample technology that will allow the fractionation of blood so that serum can be added onto the sensor.
The use of a CMOS sensor allows the device to be interfaced to electronic devices and displays, which could lead to more functional and practical devices using mobile computing. Such devices could be more easy to use and reliable than teststrips that often lack a good user interface. The results show excellent potential for the development of an early-warning device for the detection of an individual's elevated cholesterol -leading to a low-cost and commercial diagnostic tool for home cholesterol management, which could subsequently spur the development of similar products for other metabolomic health indicators using different enzyme assays. In the long term we anticipate such devices will play a major role in metabolomic science and precision medicine whereby personalized healthcare is made possible through the use of precise patient data. NOTES * Low density lipoprotein cholesterol, often termed "bad cholesterol".
